Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01888887 · ClinicalTrials.gov registry record · NA

Repeat Insult Patch Test of Skin Irritation/Sensitization for Cetaphil Daily Facial Cleanser

A NA study, sponsored by Galderma R&D.

Completed
Registry status
NA
Development phase
200
Enrollment target

NCT01888887 is a NA study that has completed, run by Galderma R&D. The registered enrollment target is 200 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01888887, a NA study, has completed, sponsored by Galderma R&D.

COMPLETED
Registry status
NA
Development phase
200 participants
Enrollment target

Study Summary

Determine if Cetaphil Daily Facial Cleanser is a contact sensitizer or irritant to the skin

Interventions

  • OTHER Cetaphil Daily Facial Cleanser

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2012-12
Phase NA

Sponsor

Galderma R&D

158 total trials

What the Registry Record Tells You About NCT01888887

The ClinicalTrials.gov registry entry for NCT01888887 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Cetaphil Daily Facial Cleanser is the first listed.

NCT01888887 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01888887 about?

NCT01888887 is a clinical study titled "Repeat Insult Patch Test of Skin Irritation/Sensitization for Cetaphil Daily Facial Cleanser". Determine if Cetaphil Daily Facial Cleanser is a contact sensitizer or irritant to the skin

What is the current status of trial NCT01888887?

This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2012-12.

What interventions are being tested in trial NCT01888887?

The interventions under investigation include: Cetaphil Daily Facial Cleanser (OTHER).

Who is sponsoring clinical trial NCT01888887?

This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.